Nil-Surin Rice Bran Hydrolysates Improve Lipid Metabolism and Hepatic Steatosis by Regulating Secretion of Adipokines and Expression of Lipid-Metabolism Genes

다국어 초록 (Multilingual Abstract)

Overconsumption of a high caloric diet is associated with metabolic disorders and a heightened risk of diabetes mellitus (DM), hepatic steatosis, and cardiovascular complications. The use of functional food has received much attention as a strategy in the prevention and treatment of metabolic disorders. This present study investigated whether Nil-Surin rice bran hydrolysates (NRH) could prevent or ameliorate the progression of metabolic disorders in rats in which insulin resistance (IR) was induced by a high fat-high fructose diet (HFFD). After 10 weeks of the HFFD, the rats showed elevated fasting blood glucose (FBG), impaired glucose tolerance, dysregulation of adipokine secretion, distorted lipid metabolism such as dyslipidemia, and increased intrahepatic fat accumulation. The IR was significantly attenuated by a daily dose of NRH (100 or 300 mg/kg/day). Doses of NRH rectified adipokine dysregulation by increasing serum adiponectin and improving hyperleptinemia. Interestingly, NRH decreased intrahepatic fat accumulation and improved dyslipidemia as shown by decreased levels of hepatic triglyceride (TG) and serum TG, total cholesterol and low-density lipoprotein cholesterol, and increased high-density lipoprotein cholesterol. In addition, a modulation of expression of lipid metabolism genes was observed: NRH prevented upregulation of the lipogenesis genes Srebf1 and Fasn. In addition, NRH enhanced the expression of fatty-acid oxidation genes, as evidenced by an increase of Ppara and Cpt1a when compared with the HFFD control group. The activities of NRH in the modulation of lipid metabolism and rectifying the dysregulation of adipokines may result in a decreased risk of DM and hepatic steatosis. Therefore, NRH may be beneficial in ameliorating metabolic disorders in the HFFD model.

참고문헌 (Reference)

1 Kim CS, "Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice" 16 : 1261-1269, 2008

2 Naowaboot J, "Vernonia cinerea water extract improves insulin resistance in high-fat diet-induced obese mice" 56 : 51-60, 2018

3 Kaewjumpol G, "The production of hydrolysates from industrially defatted rice bran and its surface image changes during extraction" 98 : 3290-3298, 2018

4 Shah A, "The effect of PPAR-alpha agonism on apolipoprotein metabolism in humans" 210 : 35-40, 2010

5 Kumar DP, "The PPAR alpha/gamma agonist saroglitazar improves insulin resistance and steatohepatitis in a diet induced animal model of nonalcoholic fatty liver disease" 10 : 9330-, 2020

6 Sutharut J, "Sudarat J : Total anthocyanin content and antioxidant activity of germinated colored rice" 19 (19): 215-221, 2012

7 Shimano H, "Sterol regulatory element-binding protein-1 as a key transcription factor for nutritional induction of lipogenic enzyme genes" 274 : 35832-35839, 1999

8 Lefebvre P, "Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis" 116 : 571-580, 2006

9 Ide T, "SREBPs suppress IRS-2-mediated insulin signalling in the liver" 6 : 351-357, 2004

10 Aragno M, "SREBP-1c in nonalcoholic fatty liver disease induced by Western-type high-fat diet plus fructose in rats" 47 : 1067-1074, 2009

11 Softic S, "Role of dietary fructose and hepatic de novo lipogenesis in fatty liver disease" 61 : 1282-1293, 2016

12 Boonloh K, "Rice bran protein hydrolysates improve insulin resistance and decrease pro-inflammatory cytokine gene expression in rats fed a high carbohydrate-high fat diet" 7 : 6313-6329, 2015

13 Boonloh K, "Rice bran protein hydrolysates attenuate diabetic nephropathy in diabetic animal model" 57 : 761-772, 2018

14 Azhar S, "Peroxisome proliferator-activated receptors, metabolic syndrome and cardiovascular disease" 6 : 657-691, 2010

15 Grygiel-Gorniak B, "Peroxisome proliferator-activated receptors and their ligands : Nutritional and clinical implications—a review" 13 : 17-, 2014

16 Monsalve FA, "Peroxisome proliferator-activated receptor targets for the treatment of metabolic diseases" 2013 : 549627-, 2013

17 Manne V, "Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis" 22 : 23-37, 2018

18 Myers MG, Jr., "Obesity and leptin resistance : Distinguishing cause from effect" 21 : 643-651, 2010

19 Jung UJ, "Obesity and its metabolic complications : The role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease" 15 : 6184-6223, 2014

20 Zhang X, "New insight into inter-organ crosstalk contributing to the pathogenesis of non-alcoholic fatty liver disease(NAFLD)" 9 : 164-177, 2018

21 Ipsen DH, "Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease" 75 : 3313-3327, 2018

22 Small L, "Modeling insulin resistance in rodents by alterations in diet : What have high-fat and high-calorie diets revealed?" 314 : E251-E265, 2018

23 Patel SB, "Leptin : Linking obesity, the metabolic syndrome, and cardiovascular disease" 10 : 131-137, 2008

24 Iyer A, "Inflammatory lipid mediators in adipocyte function and obesity" 6 : 71-82, 2010

25 Knight ZA, "Hyperleptinemia is required for the development of leptin resistance" 5 : e11376-, 2010

26 Matthews DR, "Homeostasis model assessment : Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man" 28 : 412-419, 1985

27 Balakumar M, "High-fructose diet is as detrimental as high-fat diet in the induction of insulin resistance and diabetes mediated by hepatic/pancreatic endoplasmic reticulum(ER)stress" 423 : 93-104, 2016

28 Black MH, "High-fat diet is associated with obesity-mediated insulin resistance and betacell dysfunction in Mexican Americans" 143 : 479-485, 2013

29 Basaranoglu M, "Fructose as a key player in the development of fatty liver disease" 19 : 1166-1172, 2013

30 Lionetti L, "From chronic overnutrition to insulin resistance : The role of fat-storing capacity and inflammation" 19 : 146-152, 2009

31 Ponglong J, "Ethanolic extract of Tubtim-Chumphae rice bran decreases insulin resistance and intrahepatic fat accumulation in high-fat-high-fructose diet fed rats" 12 : 505-511, 2019

32 Klop B, "Dyslipidemia in obesity : Mechanisms and potential targets" 5 : 1218-1240, 2013

33 Her TK, "Dietary carbohydrates modulate metabolic and beta-cell adaptation to high-fat diet-induced obesity" 18 : E856-E865, 2020

34 Park EJ, "Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6and TNF expression" 140 : 197-208, 2010

35 Cerf ME, "Beta cell dysfunction and insulin resistance" 4 : 37-, 2013

36 Gutch M, "Assessment of insulin sensitivity/resistance" 19 : 160-164, 2015

37 Ben Hmad Halima ; Gara Sonia ; Khlifi Sarra ; Ben Jemaa Houda ; Ben Slama Fethi ; Aouidet Abdallah, "Apple Cider Vinegar Attenuates Oxidative Stress and Reduces the Risk of Obesity in High-Fat-Fed Male Wistar Rats" 한국식품영양과학회 21 (21): 70-80, 2018

38 Nagai Y, "Amelioration of high fructose-induced metabolic derangements by activation of PPARalpha" 282 : E1180-E1190, 2002

39 Hajer GR, "Adipose tissue dysfunction in obesity, diabetes, and vascular diseases" 29 : 2959-2971, 2008

40 Kershaw EE, "Adipose tissue as an endocrine organ" 89 : 2548-2556, 2004

41 Stern JH, "Adiponectin, leptin, and fatty acids in the maintenance of metabolic homeostasis through adipose tissue crosstalk" 23 : 770-784, 2016

42 Ouchi N, "Adiponectin as an anti-inflammatory factor" 380 : 24-30, 2007

43 Okamoto Y, "Adiponectin : A key adipocytokine in metabolic syndrome" 110 : 267-278, 2006

44 Aldhahi W, "Adipokines, inflammation, and the endothelium in diabetes" 3 : 293-298, 2003